Osamu Yamazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Osamu Yamazaki has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Shigeru Shibata
Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
4 shared publications Shigeru Shibata
Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan
3 shared publicationsAtsuro Chonan
Teikyo University School of Medicine
2 shared publicationsFumika Ochiai-Homma
Division of Nephrology, Department of Internal Medicine, Teikyo University School of Medicine, Japan (Y.H., E.K.-O., F.O.-H., O.Y., S.S.).
2 shared publications- George Seki
University of Tokyo
2 shared publications - Ken Kozuma
Teikyo University School of Medicine
2 shared publications
Latest Publications
- 1 September 2026
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 331 (3) , F319-F329
A previously uncharacterized R881S variant of transporter NBCe1 exhibits intracellular retention and virtually no plasma membrane expression
Electrogenic Na + /[Formula: see text] cotransporter 1-A (NBCe1-A) in the proximal tubules regulates acid/base balance and fluid volume homeostasis. From the NCBI dbSNP database, we identified R881S NBCe1-A, which lacks glycosylation, cell-surface expression, and transport activity. We also found that the R881S variant does not form heterodimers with wild type, likely due to a reduced opportunity to interact with the wild-type protein at the plasma membrane.
- 1 September 2026
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 331 (3) , F319-F329
A previously uncharacterized R881S variant of transporter NBCe1 exhibits intracellular retention and virtually no plasma membrane expression
Electrogenic Na + /[Formula: see text] cotransporter 1-A (NBCe1-A) in the proximal tubules regulates acid/base balance and fluid volume homeostasis. From the NCBI dbSNP database, we identified R881S NBCe1-A, which lacks glycosylation, cell-surface expression, and transport activity. We also found that the R881S variant does not form heterodimers with wild type, likely due to a reduced opportunity to interact with the wild-type protein at the plasma membrane.
- 2 February 2026
- Published by Springer Nature
- p. 215-218
Infections
- Open Access
- 15 July 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (9) , 2468-2470
Silent risk of ascending artery dilatation in non-functional adrenal incidentaloma
- 15 July 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (9) , 2468-2470
Open AccessSilent risk of ascending artery dilatation in non-functional adrenal incidentaloma
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , 2457-2467
ENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism
BACKGROUND: Aldosterone and the MR (mineralocorticoid receptor) are important therapeutic targets for hypertension and cardiovascular diseases. However, biomarkers of tissue MR signaling are not fully established. Extracellular vesicles released from eukaryotic cells can provide information on tissue signaling. Using samples from patients with primary aldosteronism (PA), we explored the potential of urinary extracellular vesicles (uEVs) as a noninvasive indicator of MR signaling to guide treatment. METHODS: We analyzed proteins contained in PA uEVs by liquid chromatography tandem mass spectrometry. We narrowed down candidate biomarkers by referring to an existing database of urinary exosomes. The results were validated through Western blot analysis involving 63 patients with PA and 11 healthy volunteers. RESULTS: We identified a total of 1940 proteins in PA uEVs. Comparative analysis with the existing database narrowed down the pathways enriched in PA uEVs, which were related to diabetic complications, Rac1 signaling, and aldosterone-regulated sodium reabsorption. A closer look at the identified proteins revealed ENaCγ (epithelial Na + channel γ) peptides near the proteolytic cleavage sites, and Western blot analysis confirmed the predominant presence of cleaved ENaCγ, a marker of aldosterone signaling in renal tubules. In PA uEVs, cleaved ENaCγ showed a 4.8-fold increase compared with healthy volunteers and was significantly correlated with the aldosterone-to-renin ratio, aldosterone levels, and fractional excretion of K + . Targeted treatment in PA reduced the abundance of cleaved ENaCγ, suggesting a causal role for MR in its induction. CONCLUSIONS: This study provides a list of proteins contained in PA uEVs and suggests that ENaCγ in uEVs is a promising biomarker for renal MR signaling.
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , 2457-2467
Open AccessENaCγ in Urinary Extracellular Vesicles as an Indicator of MR Signaling in Primary Aldosteronism
BACKGROUND: Aldosterone and the MR (mineralocorticoid receptor) are important therapeutic targets for hypertension and cardiovascular diseases. However, biomarkers of tissue MR signaling are not fully established. Extracellular vesicles released from eukaryotic cells can provide information on tissue signaling. Using samples from patients with primary aldosteronism (PA), we explored the potential of urinary extracellular vesicles (uEVs) as a noninvasive indicator of MR signaling to guide treatment. METHODS: We analyzed proteins contained in PA uEVs by liquid chromatography tandem mass spectrometry. We narrowed down candidate biomarkers by referring to an existing database of urinary exosomes. The results were validated through Western blot analysis involving 63 patients with PA and 11 healthy volunteers. RESULTS: We identified a total of 1940 proteins in PA uEVs. Comparative analysis with the existing database narrowed down the pathways enriched in PA uEVs, which were related to diabetic complications, Rac1 signaling, and aldosterone-regulated sodium reabsorption. A closer look at the identified proteins revealed ENaCγ (epithelial Na + channel γ) peptides near the proteolytic cleavage sites, and Western blot analysis confirmed the predominant presence of cleaved ENaCγ, a marker of aldosterone signaling in renal tubules. In PA uEVs, cleaved ENaCγ showed a 4.8-fold increase compared with healthy volunteers and was significantly correlated with the aldosterone-to-renin ratio, aldosterone levels, and fractional excretion of K + . Targeted treatment in PA reduced the abundance of cleaved ENaCγ, suggesting a causal role for MR in its induction. CONCLUSIONS: This study provides a list of proteins contained in PA uEVs and suggests that ENaCγ in uEVs is a promising biomarker for renal MR signaling.
- Open Access
- 24 April 2024
- Published by Springer Nature in Hypertension Research
- Vol. 47 (7) , 1984-1986
Another evidence that supports the continued use of RAS inhibitors in end-stage kidney diseases
- 24 April 2024
- Published by Springer Nature in Hypertension Research
- Vol. 47 (7) , 1984-1986
Open AccessAnother evidence that supports the continued use of RAS inhibitors in end-stage kidney diseases
- 1 August 2023
- Published by Springer Nature in Hypertension Research
- Vol. 46 (10) , 1-4
Don’t miss the isolated diastolic hypertension
- 1 August 2023
- Published by Springer Nature in Hypertension Research
- Vol. 46 (10) , 1-4
Don’t miss the isolated diastolic hypertension
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 321 (6) , F771-F784
A novel I551F variant of the Na+/HCO3− cotransporter NBCe1-A shows reduced cell surface expression, resulting in diminished transport activity
Homozygous mutations in SLC4A4, encoding the electrogenic Na+/HCO3- cotransporter NBCe1, cause proximal renal tubular acidosis (pRTA) associated with extrarenal symptoms. Although 17 mutated sites in SLC4A4 have thus far been identified among pRTA patients, physiological significance of other nonsynonymous single nucleotide variants (SNVs) remains largely undetermined. Here, we investigated the functional properties of SNVs in NBCe1. From NCBI dbSNP database, we identified 13 SNVs that have not previously been characterized in highly conserved, transmembrane domains of NBCe1-A. Immunocytochemical analysis revealed that I551F variant was present predominantly in the cytoplasm in HEK293 cells, whereas all other SNVs did not show as dramatic a change in subcellular distribution. Western blot analysis in HEK293 cells demonstrated that the I551F variant showed impaired glycosylation and a 69 % reduction in cell surface levels. To determine the role of I551 in more detail, we examined the significance of various artificial mutants both in non-polarized HEK293 cells and polarized MDCK cells, which indicated that only I551F substitution resulted in cytoplasmic retention. Moreover, functional analysis using Xenopus oocytes demonstrated that the I551F variant had a significantly reduced activity corresponding to 39 % of that of wild-type, whereas any other SNVs and artificial I551 mutants did not show significant changes in activity. Finally, immunofluorescence study in HEK293 cells indicated that the I551F variant retains wild-type NBCe1-A in the cytoplasm. These data demonstrate that I551F-NBCe1-A shows impaired transport activity predominantly through cytoplasmic retention, and suggest that the variant can have a dominant-negative effect by forming complexes with wild-type NBCe1-A.
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 321 (6) , F771-F784
A novel I551F variant of the Na+/HCO3− cotransporter NBCe1-A shows reduced cell surface expression, resulting in diminished transport activity
Homozygous mutations in SLC4A4, encoding the electrogenic Na+/HCO3- cotransporter NBCe1, cause proximal renal tubular acidosis (pRTA) associated with extrarenal symptoms. Although 17 mutated sites in SLC4A4 have thus far been identified among pRTA patients, physiological significance of other nonsynonymous single nucleotide variants (SNVs) remains largely undetermined. Here, we investigated the functional properties of SNVs in NBCe1. From NCBI dbSNP database, we identified 13 SNVs that have not previously been characterized in highly conserved, transmembrane domains of NBCe1-A. Immunocytochemical analysis revealed that I551F variant was present predominantly in the cytoplasm in HEK293 cells, whereas all other SNVs did not show as dramatic a change in subcellular distribution. Western blot analysis in HEK293 cells demonstrated that the I551F variant showed impaired glycosylation and a 69 % reduction in cell surface levels. To determine the role of I551 in more detail, we examined the significance of various artificial mutants both in non-polarized HEK293 cells and polarized MDCK cells, which indicated that only I551F substitution resulted in cytoplasmic retention. Moreover, functional analysis using Xenopus oocytes demonstrated that the I551F variant had a significantly reduced activity corresponding to 39 % of that of wild-type, whereas any other SNVs and artificial I551 mutants did not show significant changes in activity. Finally, immunofluorescence study in HEK293 cells indicated that the I551F variant retains wild-type NBCe1-A in the cytoplasm. These data demonstrate that I551F-NBCe1-A shows impaired transport activity predominantly through cytoplasmic retention, and suggest that the variant can have a dominant-negative effect by forming complexes with wild-type NBCe1-A.
- Open Access
- 6 March 2019
- Published by Wiley in Case Reports in Nephrology
- Vol. 2019, 1-7
A Case of Rheumatoid Arthritis Presenting with Renal Thrombotic Microangiopathy Probably due to a Combination of Chronic Tacrolimus Arteriolopathy and Severe Hypertension
A 51-year-old woman with rheumatoid arthritis presented with mild hypertension 20 months after tacrolimus treatment and developing proteinuria 24 months after the treatment. Tacrolimus was discontinued 27 months after the treatment, followed by heavy proteinuria, accelerated hypertension, and deteriorating renal function without ocular fundus lesions as a clinical sign of malignant hypertension. Renal biopsy revealed malignant nephrosclerosis characterized by subacute and chronic thrombotic microangiopathy (TMA), involving small arteries, arterioles, and glomeruli. Focal segmental glomerulosclerosis, probably secondary to chronic TMA, was identified as a cause of heavy proteinuria. The zonal tubulointerstitial injury caused by subacute TMA may have mainly contributed to deteriorating renal function. The presence of nodular hyalinosis in arteriolar walls was indicative of tacrolimus-associated nephrotoxicity. Together with other antihypertensive drugs, administration of aliskiren stabilized renal function with reducing proteinuria. Owing to the preexisting proteinuria prior to severe hypertension and the complex renal histopathology, we postulated that chronic TMA, which was initially triggered by tacrolimus, was aggravated by severe hypertension, resulting in overt renal TMA.
- 6 March 2019
- Published by Wiley in Case Reports in Nephrology
- Vol. 2019, 1-7
Open AccessA Case of Rheumatoid Arthritis Presenting with Renal Thrombotic Microangiopathy Probably due to a Combination of Chronic Tacrolimus Arteriolopathy and Severe Hypertension
A 51-year-old woman with rheumatoid arthritis presented with mild hypertension 20 months after tacrolimus treatment and developing proteinuria 24 months after the treatment. Tacrolimus was discontinued 27 months after the treatment, followed by heavy proteinuria, accelerated hypertension, and deteriorating renal function without ocular fundus lesions as a clinical sign of malignant hypertension. Renal biopsy revealed malignant nephrosclerosis characterized by subacute and chronic thrombotic microangiopathy (TMA), involving small arteries, arterioles, and glomeruli. Focal segmental glomerulosclerosis, probably secondary to chronic TMA, was identified as a cause of heavy proteinuria. The zonal tubulointerstitial injury caused by subacute TMA may have mainly contributed to deteriorating renal function. The presence of nodular hyalinosis in arteriolar walls was indicative of tacrolimus-associated nephrotoxicity. Together with other antihypertensive drugs, administration of aliskiren stabilized renal function with reducing proteinuria. Owing to the preexisting proteinuria prior to severe hypertension and the complex renal histopathology, we postulated that chronic TMA, which was initially triggered by tacrolimus, was aggravated by severe hypertension, resulting in overt renal TMA.
- Open Access
- 28 May 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-7
Roles of Renal Proximal Tubule Transport in Acid/Base Balance and Blood Pressure Regulation
Sodium-coupled bicarbonate absorption from renal proximal tubules (PTs) plays a pivotal role in the maintenance of systemic acid/base balance. Indeed, mutations in the Na+-HCcotransporter NBCe1, which mediates a majority of bicarbonate exit from PTs, cause severe proximal renal tubular acidosis associated with ocular and other extrarenal abnormalities. Sodium transport in PTs also plays an important role in the regulation of blood pressure. For example, PT transport stimulation by insulin may be involved in the pathogenesis of hypertension associated with insulin resistance. Type 1 angiotensin (Ang) II receptors in PT are critical for blood pressure homeostasis. Paradoxically, the effects of Ang II on PT transport are known to be biphasic. Unlike in other species, however, Ang II is recently shown to dose-dependently stimulate human PT transport via nitric oxide/cGMP/ERK pathway, which may represent a novel therapeutic target in human hypertension. In this paper, we will review the physiological and pathophysiological roles of PT transport.- 28 May 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-7
Open AccessRoles of Renal Proximal Tubule Transport in Acid/Base Balance and Blood Pressure Regulation
Sodium-coupled bicarbonate absorption from renal proximal tubules (PTs) plays a pivotal role in the maintenance of systemic acid/base balance. Indeed, mutations in the Na+-HCcotransporter NBCe1, which mediates a majority of bicarbonate exit from PTs, cause severe proximal renal tubular acidosis associated with ocular and other extrarenal abnormalities. Sodium transport in PTs also plays an important role in the regulation of blood pressure. For example, PT transport stimulation by insulin may be involved in the pathogenesis of hypertension associated with insulin resistance. Type 1 angiotensin (Ang) II receptors in PT are critical for blood pressure homeostasis. Paradoxically, the effects of Ang II on PT transport are known to be biphasic. Unlike in other species, however, Ang II is recently shown to dose-dependently stimulate human PT transport via nitric oxide/cGMP/ERK pathway, which may represent a novel therapeutic target in human hypertension. In this paper, we will review the physiological and pathophysiological roles of PT transport. - 1 January 2012
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 159 (4) , H367-H372
Impacts of Chemical Supply Flow on Particle Removability in Wet Clean Bath
We found that a wet clean bath that has an interval chemical supply and a frequent flow change was quite effective for improving the cleaning performance under a constant value of total chemical supply amount. Using an interval chemical supply suggests a saving of chemical consumption which is environmentally friendly, and has a high throughput process. When wafers were placed with a wide spacing and a narrow spacing at the same time in the same wet clean bath, the particle removal efficiency was decreased noticeably at the narrow spacing compared to a wafer arrangement with equal spacing. In order to prevent the wet clean process from decreasing the cleaning performance, there must be a careful consideration of the wafer placement in the wet clean bath. Interestingly, a simulation of the supply flow velocity in a wet clean bath was correlated to experimental data of actual particle removability with various wafer spacing. We recognized that the wafer spacing and the chemical supply manner are important factors to controlling wet bath cleaning efficiency.
- 1 January 2012
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 159 (4) , H367-H372
Impacts of Chemical Supply Flow on Particle Removability in Wet Clean Bath
We found that a wet clean bath that has an interval chemical supply and a frequent flow change was quite effective for improving the cleaning performance under a constant value of total chemical supply amount. Using an interval chemical supply suggests a saving of chemical consumption which is environmentally friendly, and has a high throughput process. When wafers were placed with a wide spacing and a narrow spacing at the same time in the same wet clean bath, the particle removal efficiency was decreased noticeably at the narrow spacing compared to a wafer arrangement with equal spacing. In order to prevent the wet clean process from decreasing the cleaning performance, there must be a careful consideration of the wafer placement in the wet clean bath. Interestingly, a simulation of the supply flow velocity in a wet clean bath was correlated to experimental data of actual particle removability with various wafer spacing. We recognized that the wafer spacing and the chemical supply manner are important factors to controlling wet bath cleaning efficiency.